DMD: Mark Gleason, Chief Operating Officer

DMD.jpg

MARK PLEASE TELL OUR READERS A LITTLE SOMETHING ABOUT YOURSELF

Mark Gleason.jpg

I’ve been very involved, particularly with early stage companies, enabling them to succeed through the innovative use of technology. Throughout my career I have participated in breakthrough products in areas such as eDetailing, eSampling and live video detailing, as they have evolved to be common place in pharmaceutical marketing jargon and practice.  Our latest offering is the evolution of staid email services into a virtual census-level, state-of-the art digital service with incredible intelligence built in.  I’m both the COO and chief product developer for DMD.

WHAT MAKES DMD UNIQUE?

DMD delivers the tools that has transformed traditional medical publishers into competitive  digital publishers. We provide a direct connection to healthcare professionals (HCPs) that allows our platform to support digital innovation.  DMD's system allows healthcare professionals to opt-in and provide an accurate and preferred email contact. This means pharma marketers can have the highest level of acceptance and success through the email channel.  DMD has become the recognized leader of email data for strategic pharmaceutical marketing.

WHAT'S NEW AND EXCITING AT DMD?

DMD has patents in process describing a new method of identifying and tracking healthcare professionals across platforms and channels.  It will provide publishers and marketers an even  better way of targeting, coupled with unique user experiences that can identify new digital marketing opportunities in real-time.

HOW DO YOU SEE DMD AND RELTIO BENEFITING COMPANIES?

Making our HCP preferred email contact data directly available through Reltio Cloud and Reltio data-as-a-service (DaaS) means marketing and sales business teams can have the most accurate and up-to-date email addresses at their fingertips.  This is an amazing capability that allows pharmaceutical companies to reach out to their target HCPs at a moments notice. 

We plan to collaborate together to provide more actionable datasets through Reltio DaaS in the future. We believe that pharma companies will love taking advantage of this on demand delivery mechanism that combines our reliable email data with relevant insight to achieve better results and better targeted marketing faster.